And, later this week, Moderna vaccine expected to receive recommendation from FDA advisory panel<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Dec. 15, 2020 (HealthDay News) — The number of Americans killed by COVID-19 topped 300,000 on Monday, the same day the country launched a massive vaccination campaign to curb the spread of COVID-19.<\/p>\n
And on Tuesday morning, scientists from the U.S. Food and Drug Administration released a data review that almost guarantees a second vaccine will soon join the Pfizer vaccine that was sent out on Monday: The two-shot Moderna regimen, which is based on the same technology as the Pfizer vaccine, was found to be 94 percent effective in a clinical trial and carried no serious safety concerns. The glowing assessment positions the Moderna vaccine for approval from an FDA advisory panel that is meeting on Thursday, The Washington Post<\/em> reported.<\/p>\n As the first doses of the Pfizer vaccine made their way to the arms of health care workers around the United States, a new survey from the Kaiser Family Foundation showed that 71 percent of Americans say they will “definitely or probably” get a COVID-19 vaccine.<\/p>\n That is up from 63 percent in September, and it is a sign that a growing number of Americans are starting to trust the science behind the vaccines as they become more comfortable with the speed in which the vaccines are being developed.<\/p>\n The Washington Post<\/em> Article<\/a><\/p>\n